Number of patients: 33
Follow up: 24-month
In this study, the drug-coated balloon essential showed a good efficacy in the treatment of ISR (mostly of DES) in terms of OCT and QCA assessment, which appear to be comparable to the provided by other drug-coated balloons well supported by clinical evidence.
Clinical efficacy seems to be good and maintained on the very long term.
Published in Cardiovascular Revascularization Medicine on July 2019.
José M. de la Torre Hernandez – Universitary Hospital Marqués de Valdecilla, (Santander, SPA).